-
1Academic Journal
Συγγραφείς: M. V. Epifanova, А. А. Kostin, А. А. Epifanov, K. A. Kirillova, М. В. Епифанова, А. А. Костин, А. А. Епифанов, К. А. Кириллова
Πηγή: Andrology and Genital Surgery; Том 25, № 2 (2024); 17-30 ; Андрология и генитальная хирургия; Том 25, № 2 (2024); 17-30 ; 2412-8902 ; 2070-9781
Θεματικοί όροι: индуцированные плюрипотентные стволовые клетки, stem cells, platelet rich plasma, exosomes, spermatogonial stem cells, induced pluripotent stem cells, стволовые клетки, аутоплазма, обогащенная тромбоцитарными факторами роста, экзосомы, сперматогониальные стволовые клетки
Περιγραφή αρχείου: application/pdf
Relation: https://agx.abvpress.ru/jour/article/view/755/578; EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.; Hajiesmailpoor A., Emami P., Kondori B.J. et al. Stem cell therapy as a recent advanced approach in male infertility. Tissue Cell 2021;73:101634. DOI:10.1016/j.tice.2021.101634.; Agarwal A., Baskaran S., Parekh N. et al. Male infertility. Lancet 2021;397(10271):319-333. DOI:10.1016/S0140-6736(20)32667-2.; Mao A.S., Mooney D.J. Regenerative medicine: Current therapies and future directions. Proc Natl Acad Sci USA 2015;112(47):14452-9. DOI:10.1073/pnas.1508520112. PMID: 26598661; PMCID: PMC4664309.; Galipeau J., Sensebe L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 2018;22(6):824–833. DOI:10.1016/j.stem.2018.05.004.; Squillaro T., Peluso G., Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829–848. DOI:10.3727/096368915X689622.; Wang J., Liu C., Fujino M. et al. Stem cells as a resource for treatment of infertility-related diseases. Curr. Mol. Med 2019;19:539–546. DOI:10.2174/1566524019666190709172636.; Dunlop C.E., Telfer E.E., Anderson R.A. Ovarian stem cells— Potential roles in infertility treatment and fertility preservation. Maturitas. 2013;76:279–283. DOI:10.1016/j.maturitas.2013.04.017.; Pourmoghadam Z., Aghebati-Maleki L., Motalebnezhad M. et al. Current approaches for the treatment of male infertility with stem cell therapy. J Cell Physiol 2018;233(10):6455–6469.; Lorzadeh N., Kazemirad N. Embryonic Stem Cells and Infertility. Am J Perinatol 2018;35(10):925-930. DOI:10.1055/s-0038-1632367.; Saha S., Roy P., Corbitt C. et al. Application of Stem Cell Therapy for Infertility. Cells 2021;10(7):1613. DOI:10.3390/cells10071613.; Geijsen N., Horoschak M., Kim K. et al. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 2004;427(6970):148–154.; Zhao X.Y., Li W., Lv Z. et al. Viable fertile mice generated from fully pluripotent iPS cells derived from adult somatic cells. Stem Cell Rev 2010;6(03):390–397.; Nayernia K., Nolte J., Michelmann H.W. et al. In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev Cell 2006;11(01):125–132.; Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–676. DOI:10.1016/j.cell.2006.07.024.; Fang F., Li Z., Zhao Q. et al. Human induced pluripotent stem cells and male infertility: An overview of current progress and perspectives. Hum. Reprod 2018;33:188–195. DOI:10.1093/humrep/dex369.; Eguizabal C., Montserrat N., Vassena R. et al. Complete meiosis from human induced pluripotent stem cells. Stem Cells 2011;29:1186–1195. DOI:10.1002/stem.672.; Ramathal C., Durruthy-Durruthy J., Sukhwani M. et al. Fate of iPSCs derived from azoospermic and fertile men following xenotransplantation to murine seminiferous tubules. Cell Rep 2014;7:1284–1297. DOI:10.1016/j.celrep.2014.03.067.; Irie N., Weinberger L., Tang W.W. et al. SOX17 is a critical specifier of human primordial germ cell fate. Cell 2015;160:253–268. DOI:10.1016/j.cell.2014.12.013.; Sasaki K., Yokobayashi S., Nakamura T. et al. Robust In Vitro induction of human germ cell fate from pluripotent stem cells. Cell Stem Cell 2015;17:178–194. DOI:10.1016/j.stem.2015.06.014.; Volarevic V., Bojic S., Nurkovic J. et al. Stem cells as new agents for the treatment of infertility: Current and future perspectives and challenges. Biomed Res Int 2014;2014:507234. DOI:10.1155/2014/507234.; Zhu Y., Hu H.-L., Li P. et al. Generation of male germ cells from induced pluripotent stem cells (iPS cells): An in vitro and in vivo study. Asian J Androl 2012;14(4):574-9. DOI:10.1038/aja.2012.3.; Cai H., Xia X., Wang L. et al. In vitro and in vivo differentiation of induced pluripotent stem cells into male germ cells. Biochem Biophys Res Commun 2013;433(3):286-291. DOI:10.1016/j.bbrc.2013.02.107.; Yamashiro C., Sasaki K., Yabuta Y. et al. Generation of human oogonia from induced pluripotent stem cells In Vitro. Science 2018;362:356-360. DOI:10.1126/science.aat1674.; Lee A.S., Tang C., Rao M.S. et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 2013;19(8):998-1004. DOI:10.1038/nm.3267.; Amidi F., Ataie Nejad N., Agha Hoseini M. et al. In vitro differentiation process of human Wharton’s jelly mesenchymal stem cells to male germ cells in the presence of gonadal and non-gonadal conditioned media with retinoic acid. In Vitro Cell Dev Biol Anim 2015;51(10): 1093–1101. DOI:10.1007/s11626-015-9929-4.; Abd Allah S.H., Pasha H.F., Abdelrahman A.A. et al. Molecular effect of human umbilical cord blood CD34-positive and CD34-negative stem cells and their conjugate in azoospermic mice. Mol Cell Biochem 2017;428(1-2):179-191. DOI:10.1007/s11010-016-2928-2.; Chen H., Tang Q.L., Wu X.Y. et al. Differentiation of human umbilical cord mesenchymal stem cells into germ-like cells in mouse seminiferous tubules. Mol Med Rep 2015;12(1):819-828. DOI:10.3892/mmr.2015.3528.; Tsekouras A., Mantas D., Tsilimigras D.I. et al. Comparison of the Viability and Yield of Adipose-Derived Stem Cells (ASCs) from Different Donor Areas. In Vivo 2017;31(6):1229-1234. DOI:10.21873/invivo.11196.; Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64(2):278-94. DOI:10.1002/(sici)1097-4644(199702)64:23.0.co;2-f.; Pittenger M.F., Mackay A.M., Beck S.C. et a. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7. DOI:10.1126/science.284.5411.143.; Vangsness C.T. Jr., Sternberg H., Harris L. Umbilical Cord Tissue Offers the Greatest Number of Harvestable Mesenchymal Stem Cells for Research and Clinical Application: A Literature Review of Different Harvest Sites. Arthroscopy 2015;31(9):1836-43. DOI:10.1016/j.arthro.2015.03.014.; Hernigou P., Homma Y., Flouzat Lachaniette C.H. et al. Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells. Int Orthop 2013;37(11):2279-87. DOI:10.1007/s00264-013-2017-z.; Li C.Y., Wu X.Y. Tong J.B. et al. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther 2015;6(1):55. DOI:10.1186/s13287-015-0066-5.; Tamadon A., Zhan-Byrbekuly U., Kairgaliyev I. et al. Mesenchymal stem cell therapy of male infertility. Male Reproductive Health, IntechOpen. 2019;105–112. DOI:10.5772/intechopen.88343; Monsef M., Fereydouni B., Rohani L. et al. Mesenchymal stem cells repair germinal cells of seminiferous tubules of sterile rats. Iran J Reprod Med 2013;11:537–44.; Vahdati A., Fathi A., Hajihoseini M. et al. The regenerative efect of bone marrow-derived stem cells in spermatogenesis of infertile hamster. World journal of plastic surgery 2017;6(1):18–25.; Cakici C., Buyrukcu B., Duruksu G. et al. Recovery of fertility in azoospermia rats after injection of adipose-tissue-derived mesenchymal stem cells: the sperm generation. Biomed Res Int 2013;2013:1–18.; Ghasemzadeh-Hasankolaei M., Batavani R., Eslaminejad M.B. et al. Transplantation of autologous bone marrow mesenchymalstem cells into the testes of infertile male rats and new germ cell formation. Int J Stem Cells 2016;9:250–63. DOI:10.15283/ijsc16010.; Zhang D., Liu X., Peng J. et al. Potential spermatogenesis recovery with bone marrow mesenchymal stem cells in an azoospermic rat model. Int J Mol Sci 2014;15:13151–65. DOI:10.3390/ijms150813151.; Hassan A.I., Alam S.S. Evaluation of mesenchymal stem cells in treatment of infertility in male rats. Stem Cell Res Ther 2014;5:131. DOI:10.1186/scrt521.; Karimaghai N., Tamadon A., Rahmanifar F. et al. Spermatogenesis after transplantation of adipose tissue-derived mesenchymal stem cells in busulfan-induced azoospermic hamster. Iran J Basic Med Sci 2018;21:660.; Mehrabani D., Hassanshahi M.A., Tamadon A. et al. Adipose tissue-derived mesenchymal stem cells repair germinal cells of seminiferous tubules of busulfan-induced azoospermic rats. J Hum Reprod Sci 2015;8(2):103-110. DOI:10.4103/0974-1208.158618.; Hsiao C.H., Ji A.T., Chang C.C. et al. Local injection of mesenchymal stem cells protects testicular torsion-induced germ cell injury. Stem Cell Res Ther 2015;6(1):113. DOI:10.1186/s13287-015-0079-0.; Sherif I.O., Sabry D., Abdel-Aziz A. et al. The role of mesenchymal stem cells in chemotherapy-induced gonadotoxicity. Stem Cell Res Ther 2018;9(1):196. DOI:10.1186/s13287-018-0946-6.; Ganjibakhsh M., Mehraein F., Koruji M. et al. The therapeutic potential of adipose tissue-derived mesenchymal stromal cells in the treatment of busulfan-induced azoospermic mice. J Assist Reprod Genet 2022;39(1):153-163. DOI:10.1007/s10815-021-02309-8.; Zhankina R., Afshar A., Farrar Z. et al. Restoration of spermatogenesis in azoospermic mice by bone marrow mesenchymal stromal/stem cells conditioned medium, 04 February 2022, PREPRINT (Version 2) available at Research Square DOI:10.21203/rs.3.rs-169243/v2.; Tamadon A., Mehrabani D., Rahmanifar F. et al. Induction of Spermatogenesis by Bone Marrow-derived Mesenchymal Stem Cells in Busulfan-induced Azoospermia in Hamster. Int J Stem Cells 2015;8(2):134-145. DOI:10.15283/ijsc.2015.8.2.134.; Hajihoseini M., Vahdati A., Ebrahim Hosseini S. et al. Induction of spermatogenesis after stem cell therapy of azoospermic guinea pigs. Vet Arh 2017;87(3): 333–350.; Aghamir S.M., Salavati A., Yousefie R. et al. Does bone marrow-derived mesenchymal stem cell transfusion prevent antisperm antibody production after traumatic testis rupture? Urology 2014;84(1): 82–86.; Xu L., Liu Y., Sun Y. et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther 2017;8(1):275.; Bakry S. MSCs For Treatment of Azoospermic Patients. Доступно по: https://clinicaltrials.gov/study/NCT02025270.; AlZoubi A. Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility. Доступно по: https://clinicaltrials.gov/study/NCT02641769.; Gadalla K.A. Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia. Доступно по: https://classic.clinicaltrials.gov/ct2/show/NCT02008799.; Elshaer H.S. Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia. Доступно по: https://classic.clinicaltrials.gov/ct2/show/NCT02041910; Volchkov S. Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for Male Patients With Infertility. Доступно по: https://classic.clinicaltrials.gov/ct2/show/NCT03762967.; Gadalla K.A. Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection. Доступно по: https://clinicaltrials.gov/study/NCT02414295.; Ryu B.Y., Orwig K.E., Oatley J.M. et al. Effects of aging and niche microenvironment on spermatogonial stem cell self-renewal. Stem Cells 2006;24(6):1505-1511. DOI:10.1634/stemcells.2005-0580.; Vlajković S., Cukuranović R., Bjelaković M.D. et al. Possible therapeutic use of spermatogonial stem cells in the treatment of male infertility: a brief overview. Scientific World Journal 2012;2012:374151. DOI:10.1100/2012/374151.; Melo-Narváez M.C., Stegmayr J., Wagner D.E. et al. Lung regeneration: implications of the diseased niche and ageing. Eur Respir Rev 2020;29:200222. DOI:10.1183/16000617.0222-2020.; Shao H., Im H. New technologies for analysis of extracellular vesicles. Chem Rev 2018;118(4):1917–1950. DOI:10.1021/acs.chemrev.7b00534.; Heldring N., Mager I., Wood M.J.A. et al. Therapeutic potential of multipotent mesenchymal stromal cells and their extracellular vesicles. Hum Gene Ther 2015;26(8):506–517. DOI:10.1089/hum.2015.072.; Mendt M., Rezvani K., Shpall E. Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant 2019;54:789–792. DOI:10.1038/s41409-019-0616-z.; Shao L.B., Zhang Y., Lan B.B. et al. MiRNA-sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair. Biomed Res Int 2017 DOI:10.1155/2017/4150705.; Pelizzo G., Avanzini M.A., Cornaglia A.I. et al. Extracellular vesicles derived from mesenchymal cells: perspective treatment for cutaneous wound healing in pediatrics. Regen Med 2018;13(4):385–94. DOI:10.2217/rme-2018-0001.; Clark K., Zhang S., Barthe S. et al. Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis. Cells 2019;8(12):1497. DOI:10.3390/cells8121497.; Kharazi U., Badalzadeh R. A review on the stem cell therapy and an introduction to exosomes as a new tool in reproductive medicine. Reprod Biol 2020;20(4):447-459. DOI:10.1016/j.repbio.2020.07.002.; Mobarak H., Heidarpour M., Rahbarghazi R. et al. Amniotic fluid-derived exosomes improved spermatogenesis in a rat model of azoospermia. Life Sci 2021;274:119336. DOI:10.1016/j.lfs.2021.119336.; McLean D.J. Spermatogonial stem cell transplantation, testicular function, and restoration of male fertility in mice. Methods Mol Biol 2008;450:149-162. DOI:10.1007/978-1-60327-214-8_11.; Ibtisham F., Honaramooz A. Spermatogonial Stem Cells for In Vitro Spermatogenesis and In Vivo Restoration of Fertility. Cells 2020;9(3):745. DOI:10.3390/cells9030745.; Kubota H., Brinster R.L. Spermatogonial stem cells. Biol Reprod 2018;99(1):52-74. DOI:10.1093/biolre/ioy077.; Forbes C.M., Flannigan R., Schlegel P.N. Spermatogonial Stem Cell Transplantation and Male Infertility: Current Status and Future Directions. Arab J Urol 2018;16:171–80.; Gul M., Hildorf S., Dong L. et al. Review of Injection Techniques for Spermatogonial Stem Cell Transplantation. Hum Reprod Update 2020; 26:368–91.; Honaramooz A., Behboodi E., Megee S.O. et al. Fertility and germline transmission of donor haplotype following germ cell transplantation in immunocompetent goats. Biol Reprod 2003;69(4):1260-1264. DOI:10.1095/biolreprod.103.018788.; Herrid M., Olejnik J., Jackson M. et al. Irradiation enhances the efficiency of testicular germ cell transplantation in sheep. Biol Reprod 2009;81(5):898-905. DOI:10.1095/biolreprod.109.078279.; Kanatsu-Shinohara M., Morimoto H., Shinohara T. Fertility of Male Germline Stem Cells Following Spermatogonial Transplantation in Infertile Mouse Models. Biol Reprod 2016;94(5):112. DOI:10.1095/biolreprod.115.137869.; Hermann B.P., Sukhwani M., Winkler F. et al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell 2012;11(5):715-726. DOI:10.1016/j.stem.2012.07.017.; Azizollahi S., Aflatoonian R., Sadighi Gilani M.A. et al. Alteration of spermatogenesis following spermatogonial stem cells transplantation in testicular torsion-detorsion mice. J Assist Reprod Genet 2016;33(6):771-781. DOI:10.1007/s10815-016-0708-2.; Skaletsky N.N., Skaletskaya G.N., Sevastianov V. I. Possible use of spermatogonial stem cells in the treatment of male infertility. Russian Journal of Transplantology and Artificial Organs 2020;21(4):134 DOI:10.15825/1995-1191-2019-4-134-142.; Liu H.C., Xie Y., Deng C.H. et al. Stem cell-based therapies for fertility preservation in males: Current status and future prospects. World J Stem Cells 2020;12(10):1097-1112. DOI:10.4252/wjsc.v12.i10.1097.; Sagaradze G.D., Basalova N.A., Efimenko A.Y. et al. Mesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration. Front Cell Dev Biol 2020;8:576176. DOI:10.3389/fcell.2020.576176.; Teymur H., Tiftikcioglu Y.O., Cavusoglu T. et al. Effect of platelet-rich plasma on reconstruction with nerve autografts. Kaohsiung J Med Sci 2017;33(2):69-77. DOI:10.1016/j.kjms.2016.11.005.; Cecerska-Heryć E., Goszka M., Serwin N. et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev 2022;64:84-94. DOI:10.1016/j.cytogfr.2021.11.003.; Hesseler M.J., Shyam N. Platelet-rich plasma and its utility in medical dermatology: A systematic review. J Am Acad Dermatol 2019;81(3):834-846. DOI:10.1016/j.jaad.2019.04.037.; Zaporozhan V., Kholodkova O., Kuleshova O. Platelet-rich plasma induces morphofunctional restoration of mice testes following doxorubomycine hydrochloride exposure. J Exp Clin Med 2014;31:183-187.; Dehghani F., Sotoude N., Bordbar H. et al. The use of platelet-rich plasma (PRP) to improve structural impairment of rat testis induced by busulfan. Platelets 2019;30(4):513-520. DOI:10.1080/09537104.2018.1478400.; Sekerci C.A., Tanidir Y., Sener T.E. et al. Effects of platelet-rich plasma against experimental ischemia/reperfusion injury in rat testis. J Pediatr Urol 2017;13(3):317.e1-317.e9. DOI:10.1016/j.jpurol.2016.12.016.; Bader R., Ibrahim J.N., Moussa M. et al. In vitro effect of autologous platelet-rich plasma on H2O2 -induced oxidative stress in human spermatozoa. Andrology 2020;8(1):191-200. DOI:10.1111/andr.12648.; Al-Nasser R., Khrait Z., Jamali S. The Effectiveness of Autologous Platelet-Rich Plasma (PRP) in the Therapy of Infertile Men with Non-Abstractive Azoospermia. J Reprod Med Gynecol Obstet 2018;3: 011.; Gudelci T., Cakiroglu Y., Yuceturk A. et al. The effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and ivf outcomes in men with non-obstructive azoospermia and history of failed testicular sperm extraction. Fertility and Sterility 2021; 116 (3) Supplement:E331. DOI:10.1016/j.fertnstert.2021.07.893.; Angellee J., Novalinda Ginting C., Chiuman L. et al. Role of Platelet-Rich Plasma to Sperm Quality in Male Partners Undergoing Infertility Treatment. IEEE International Conference on Health, Instrumentation & Measurement, and Natural Sciences (InHeNce) 2021;1: 1-5. DOI:10.1109/InHeNce52833.2021.9537240.; Mirzaei J., Movahedin M., Halvaei I. Plasma-Rich in Growth Factors Ameliorates Detrimental Effects of Cryopreservation on Human Sperm: A Prospective Study. Cell J 2022;24(6):330-336. DOI:10.22074/cellj.2022.8119.; Yan B., Zhang Y., Tian S. et al. Effect of autologous platelet-rich plasma on human sperm quality during cryopreservation. Cryobiology 2021;98:12-16. DOI:10.1016/j.cryobiol.2021.01.009.; Salem M., Feizollahi N., Jabari A. et al. Differentiation of human spermatogonial stem cells using a human decellularized testicular scaffold supplemented by platelet-rich plasma. Artif Organs 2023;47(5):840-853. DOI:10.1111/aor.14505.; Tiras B. The Effects of Intratesticular PRP Injection in Men With Azoospermia or Cryptozoospermia. Доступно по: https://classic.clinicaltrials.gov/ct2/show/NCT04237779; Епифанова, М.В. Применение технологий регенеративной медицины при сексуальной дисфункции и нарушении фертильности у мужчин : дис. . д-р. мед. наук : 3.1.13 / Епифанова Майя Владимировна. – М., 2021. – 400 с.; Епифанова М.В., Епифанов А.А., Артеменко С.А. Способ протекции и восстановления сперматогенеза при оперативных вмешательствах на семенном канатике, яичке, придатке яичка. – Патент на изобретение РФ №2735888. Москва. 09 ноября 2020. // Бюллетень No 31 от 09.11.2020; Епифанова М.В., Епифанов А.А., Артеменко С.А. Способ лечения мужского бесплодия. – Патент на изобретение РФ №2738543. Москва. 14 декабря 2020. // Бюллетень No 35 от 14.12.2020; https://agx.abvpress.ru/jour/article/view/755
-
2Academic Journal
Συγγραφείς: A. Pakhomova V., O. Pershina V., V. Krupin A., L. Ermolaeva A., N. Ermakova N., A. Kudryashova I., A. Dygai M., E. Pan S., O. Rybalkina Yu., E. Skurikhin G., А. Пахомова В., О. Першина В., В. Крупин А., Л. Ермолаева А., Н. Ермакова Н., А. Кудряшова И., А. Дыгай М., Э. Пан С., О. Рыбалкина Ю., Е. Скурихин Г.
Συνεισφορές: Авторы выражают свою признательность генеральному директору ООО «ФАРМИНТЕРПРАЙСЕЗ» канд. хим. наук Небольсину Владимиру Евгеньевичу за предоставленные реактивы.
Πηγή: Bulletin of Siberian Medicine; Том 16, № 4 (2017); 220-232 ; Бюллетень сибирской медицины; Том 16, № 4 (2017); 220-232 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2017-16-4
Θεματικοί όροι: metabolic disorders, inflammation, diabetes mellitus, hypogonadism, spermatogonial stem cells, precursors of hemangiogenesis, precursors of β-cells, regeneration, метаболические нарушения, воспаление, диабет, гипогонадизм, сперматогониальные стволовые клетки, предшественники гемангиогенеза, предшественники β-клеток, регенерация
Περιγραφή αρχείου: application/pdf
Relation: https://bulletin.tomsk.ru/jour/article/view/1039/760; Рекомендации ýкспертов Всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома. Второй пересмотр // Практическая медицина. 2010; 44: 81–101. Rekomendatsii ekspertov Vserossiyskogo nauchnogo obshchestva kardiologov po diagnostike i lecheniyu metabolicheskogo sindroma. Vtoroy peresmotr [Recommendations of the experts of the All-russian scientific society of cardiologists on diagnosis and treatment of metabolic syndrome. Second revision] // Prakticheskaya meditsina – Practical Medicine. 2010; 44: 81–101 (in Russian).; Мамедов М.Н. Руководство по диагностике и лечению метаболического синдрома: Методические рекомендации. М., 2004: 72. Mamedov M.N. Rukovodstvo po diagnostike i lecheniyu metabolicheskogo sindroma: Metodicheskie rekomendatsii [Manual on diagnosis and treatment of metabolic syndrome: Methodological recommendations]. M., 2004: 72 (in Russian).; Чазова И.Е., Мычка В.Б. Метаболический синдром. М.: Медиа Медика, 2004: 168. Chazova I.E., Mychka V.B. Metabolicheskiy sindrom [Metabolic Syndrome]. M.: Media Medika Publ., 2004: 168 (in Russian).; Кравец Е.Б., Самойлова Ю.Г., Матюшева Н.Б., Буланова А.А., Дорохова В.В., Ядмаа О. Метаболический синдром в общеврачебной практике // Бюллетень сибирской медицины. 2008; 1: 80–87. Kravets E.B., Samoylova Yu.G., Matyusheva N.B., Bulanova A.A., Dorokhova V.V., Yadmaa O. Metabolicheskiy sindrom v obshchevrachebnoy praktike [Metabolic syndrome in general medical practice] // Byulleten’ sibirskoy meditsiny – Bulletin of Siberian Medicine. 2008; 1: 80–87 (in Russian).; Тишова Ю.А., Калинченко С.Ю. Роль коррекции гипогонадизма в лечении метаболического синдрома у мужчин и аспекты безопасности терапии препаратом тестостерона пролонгированного действия // Ожирение и метаболизм. 2010; 2: 36–43. Tishova Yu.A., Kalinchenko S.Yu. Rol’ korrektsii gipogonadizma v lechenii metabolicheskogo sindroma u muzhchin i aspekty bezopasnosti terapii preparatom testosterona prolongirovannogo deystviya [The role of correction of hypogonadism in the treatment of metabolic syndrome in men and safety aspects of testosterone with prolonged action] // Ozhirenie i metabolism – Obesity and Metabolism. 2010; 2: 36–43 (in Russian).; Бутрова С.А., Дзогоева Ф.Х. Висцеральное ожирение – ключевое звено метаболического синдрома // Ожирение и метаболизм. 2004; 1: 10–16. Butrova S.A., Dzogoeva F.Kh. Vistseral’noe ozhirenie – klyuchevoe zveno metabolicheskogo sindroma [The role of correction of hypogonadism in the treatment of metabolic syndrome in men and aspects of safety of therapy with a long-acting testosterone drug] // Ozhirenie i metabolism – Obesity and Metabolism. 2004; 1: 10–16 (in Russian).; Мкртумян А.М. Особенности течения и лечения нарушений углеводного обмена при метаболическом синдроме // Сердце. 2005; 4–5 (23): 273–276. Mkrtumyan A.M. Osobennosti techeniya i lecheniya narusheniy uglevodnogo obmena pri metabolicheskom sindrome [Features of the course and treatment of disorders of carbohydrate metabolism in metabolic syndrome] // Serdtse – Russian Heart Journal. 2005; 4–5 (23): 273–276 (in Russian).; Мамедов М.Н. Возможны ли диагностика и лечение метаболического синдрома в реальной практике? // Лечащий врач. 2006; 6: 34–39. Mamedov M.N. Vozmozhny li diagnostika i lechenie metabolicheskogo sindroma v real’noy praktike? [Is it possible to diagnose and treat the metabolic syndrome in real practice?] // Lechashchiy vrach. 2006; 6: 34–39 (in Russian).; Rask-Madsen C., Kahn C. R. Tissue-specific insulin signaling, metabolic syndrome and cardiovascular disease // Arterioscler. Thromb. Vasc. Biol. 2012; 32 (9): 2052– 2059. DOI:10.1161/ATVBAHA. 111.241919.; Урясьев О.М., Горбунова Д.Ю., Щербакова О.Н., Пыко А.А. Метаболический синдром – нерешенная проблема медицины и современного общества // Вестник Смоленской государственной медицинской академии. 2017; 16 (1): 160–164. Uryas’ev O.M., Gorbunova D.Yu., Shcherbakova O.N., Pyko A.A. Metabolicheskiy sindrom – nereshennaya problema meditsiny i sovremennogo obshchestva [Metabolic syndrome - the unresolved problem of medicine and modern society] // Vestnik Smolenskoy gosudarstvennoy meditsinskoy akademii. 2017; 16 (1): 160–164 (in Russian).; Mamedov M., Suslonova N., Lisenkova I. Metabolic syndrome prevalence in Russia: Prelimonary results of a cross-sectional population study // Diab. Vasc. Dis. Res. 2007; 4(1): 46–47.; Волков В.П. Метаболический синдром: история вопроса // Universum: медицина и фармакология. 2017; 38 (4): 36–45. Volkov V.P. Metabolicheskiy sindrom: istoriya voprosa [Metabolic syndrome: the history of the issue] // Universum: meditsina i farmakologiya. 2017; 38 (4): 36–45 (in Russian).; Метаболический синдром / под ред. чл.-корр. РАМН Г.Е. Ройтберг. М.: МЕД Пресс-информ. 2007: 224. Metabolicheskiy sindrom [Metabolicheskiy sindrom] / pod red. chl.-korr. RAMN G.E. Roytberg. M.: MED Press-inform Publ., 2007: 224 (in Russian).; Ольховский Д.В. Гиперурикемия и метаболический синдром у больных хронической сердечной недостаточностью // Медицина сегодня и завтра. 2007; 3: 82–86. Ol’khovskiy D.V. Giperurikemiya i metabolicheskiy sindrom u bol’nykh khronicheskoy serdechnoy nedostatochnost’yu [Hyperuricemia and metabolic syndrome in patients with chronic heart failure] // Meditsina segodnya i zavtra. 2007; 3: 82–86 (in Russian).; Мамедов М. Н. Школа по диагностике и лечению гиперлипидемий: пособие для врачей. М.: Изд. Пфайзер, 2007: 317. Mamedov M. N. Shkola po diagnostike i lecheniyu giperlipidemiy (Posobie dlya vrachey) [School for the diagnosis and treatment of hyperlipidemia: a manual for doctors]. M.: Izd. Pfayzer Publ., 2007: 317 (in Russian).; Оганов Р.Г. Современные представления о метаболическом синдроме: понятие, ýпидемиология, риск раз- вития сердечно-сосудистых осложнений и сахарного диабета // Международный эндокринологический журнал. 2008; 6 (18): 15–21. Oganov R.G. Sovremennye predstavleniya o metabolicheskom sindrome: ponyatie, epidemiologiya, risk razvitiya serdechno-sosudistykh oslozhneniy i sakharnogo diabeta [Modern concepts of the metabolic syndrome: concept, epidemiology, risk of cardiovascular complications and diabetes mellitus, International] // Mezhdunarodnyy endokrinologicheskiy zhurnal – Endocrinology Journal. 2008; 6 (18): 15–21 (in Russian).; Wespes E. Metabolic syndrome and hypogonadism // European Urology Supplements. 2013; 12 (2): 2–6. DOI:10.1016/j.eursup.2013.03.003.; Калинченко С.Ю., Тишова Ю.А. Роль коррекции гипогонадизма в лечении метаболического синдрома у мужчин // Ожирение и метаболизм. 2006; 2: 48–51. Kalinchenko S.Yu., Tishova Yu.A. Rol’ korrektsii gipogonadizma v lechenii metabolicheskogo sindroma u muzhchin [The role of correction of hypogonadism in the treatment of metabolic syndrome in men] // Ozhirenie i metabolism – Obesity and Metabolism. 2006; 2: 48–51 (in Russian).; Оранская А.Н., Романова Е.В., Мкртумян А.М. Зна- чение инсулинрезистентности в нарушении половой функции мужчин (обзор) // Вестник новых медицинских технологий. 2009; 16 (1): 55–56. Oranskaya A.N., Romanova E.V., Mkrtumyan A.M. Znachenie insulinrezistentnosti v narushenii polovoy funktsii muzhchin (obzor) [The importance of insulin resistance in the violation of men’s sexual function (review)] // Vestnik novykh meditsinskikh tekhnologiy. 2009; 16 (1): 55–56 (in Russian).; Савельева Л.В., Роживанов Р.В., Шурдумова Б.О., Фадеев В.В. Нормогонадотропный гипогонадизм у мужчин с ожирением // Ожирение и метаболизм. 2009; 3: 39–42. Savel’eva L.V., Rozhivanov R.V., Shurdumova B.O., Fadeev V.V. Normogonadotropnyy gipogonadizm u muzhchin s ozhireniem [Normogonadotropic hypogonadism in obese men] // Ozhirenie i metabolism – Obesity and Metabolism. 2009; 3: 39–42 (in Russian).; Ebrahimi F., Christ-Crain M. Metabolic syndrome and hypogonadism--two peas in a pod // Swiss. Med. Wkly. 2016; 21 (146): 14283. DOI:10.4414/smw.2016.14283.; Gorbachinsky I., Akpinar H., Assimos D.G. Metabolic syndrome and urologic diseases // Rev. Urol. 2010; 12 (4): 157–180. DOI:10.3909/riu0487.; Роживанов Р.В., Яшина Ю.Н. Аспекты применения андрогенной заместительной терапии при лечении гипогонадизма у мужчин с сахарным диабетом и метаболическом синдромом // Ожирение и метаболизм. 2015; 12 (1): 11–14. Rozhivanov R.V., Yashina Yu.N. Aspekty primeneniya androgennoy zamestitel’noy terapii pri lechenii gipogonadizma u muzhchin s sakharnym diabetom i metabolicheskom sindromom [Aspects of androgen replacement therapy in the treatment of hypogonadism in men with diabetes mellitus and metabolic syndrome] // Ozhirenie i metabolism – Obesity and Metabolism. 2015; 12 (1): 11–14 (in Russian).; Дыгай А.М., Скурихин Е.Г., Ермакова Н.Н., Пахомова А.В., Першина О.В., Крупин В.А., Кудряшова А.И. Пат. 2611936 RU, МПК G09B 23/28. Способ моделирования гипогонадизма, вызванного метаболическими нарушениями. № 2016105189; Заявл. 16.02.2016; Опубл. 01.03.2017. Бюл. № 7. Dygay A.M., Skurikhin E.G., Ermakova N.N., Pakhomova A.V., Pershina O.V., Krupin V.A., Kudryashova A.I. Pat. 2611936 RU, MPK G09B 23/28. Sposob modelirovaniya gipogonadizma, vyzvannogo metabolicheskimi narusheniyami [Method for modeling hypogonadism caused by metabolic disorders]. № 2016105189; Zayavl. 16.02.2016; Opubl. 01.03.2017. Byul. № 7 (in Russian).; Skurikhin E.G., Pakhomova A.V., Ermakova N.N., Pershina O.V., Pan E.S., Ermolaeva L.A., Kudryashova A.I., Krupin V.A., Rybalkina O.Y., Dygai A.M. Response of stem and progenitor cells to testicular ischemia // Bull. Exp. Biol. Med. 2016; 161(4): 523–528. DOI:10.1007/ s10517-016-3452-9.; Skurikhin E.G., Ermakova N.N., Khmelevskaya E.S., Pershina O.V., Krupin V.A., Ermolaeva L.A., Dygai A.M. Differentiation of pancreatic stem and progenitor β-cells into insulin secreting cells in mice with diabetes mellitus // Bull. Exp. Biol. Med. 2014; 156 (6): 726–730. DOI:10.1007/s10517-014-2434-z.; Kanatsu-Shinohara M., Ogonuki N., Inoue K., Ogura A, Toyokuni S, Honjo T, Shinohara T. Allogeneic Offspring Produced by Male Germ Line Stem Cell Transplantation into Infertile Mouse Testis // Biol. Reprod. 2003; 69: 612–616. DOI:10.1095/biolreprod.102.008516.; Ogawa T., Aréchaga J.M., Avarbock M.R., Brinster R.L. Transplantation of testis germinal cells into mouse seminiferous tubules // Int. J. Dev. Biol. 1997; 41: 111–122. PMID: 9074943.; Биология стволовых клеток и клеточные технологии. Т. 2; под ред. М.А. Пальцева. М.: Медицина, 2009: 456. Biologiya stvolovykh kletok i kletochnye tekhnologii. T. 2. pod red. M.A. Pal’tseva [Cell Biology and Cell Technologies. V. 2 / ed. M.A. Paltseva]. M.: Meditsina Publ., 2009: 456 (in Russian).; Mari A., Akiren B., Pacini G. Assessment of insulin secretion in relation to insulin resistance // Curr. Opin. Clin. Metab. Care. 2005; 8 (5): 529–533. DOI:10.4103/2230- 8210.146874.; Katz A., Nambi S., Mather K., Baron A., Follman D., Sulivan G., Quon M. Quantitative insulin sensitivity check index: A Simple Accurate Method for Assessing Insulin Sensitivity in Humans // J. Clin. Endocrinol. Metab. 2000; 85 (7): 2402–2410. DOI:10.1210/jcem.85.7.6661.; Zheng Y., Zhang Y., Qu R., He Y., Tian X., Zeng W. Spermatogonial stem cells from domestic animals: progress and prospects // Reproduction. 2014; 147: 65–74. DOI:10.1530/REP-13-0466.; Zang Z. J., Wang J., Chen Z., Zhang Y., Gao Y., Su Z., Tuo Y., Liao Y., Zhang M., Yuan Q., Deng C., Jiang M. H., Xiang A. P. Regenerative Medicine Transplantation of CD51+ Stem Leydig cells: A New Strategy for the Treatment of Testosterone Deficiency // Stem Cells. 2017; 35(5): 1222–1232. DOI:10.1002/stem.2569.; Bonner-Weir S., Taneja M., Weir G.C., Tatarkiewicz K., Song K.H., Sharma A., O’Neil J.J. In vitro cultivation of human islets from expanded ductal tissue // Proc. Natl. Acad. Sci. USA. 2000; 97 (14): 7999–8004. PMID: 10884429; Suzuki A., Nakauchi H., Taniguchi H. Prospective Isolation of Multipotent Pancreatic Progenitors Using Flow-Cytometric Cell Sorting // Diabetes. 2004; 53(8): 2143–2152. PMID: 15277399.; Zhang M., Zhou H., Zheng C. Xiao J., Zuo E., Liu W., Xie D., Shi Y., Wu C., Wang H., Li D., Li J. The Roles of Testicular C-kit Positive Cells in De novo Morphogenesis of Testis // Scientific Reports. 2014; 4: 5936. DOI:10.1038/srep05936.; Matthews D.R., Hosker J.P., Rudenski A.S. et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man // Diabetologia. 1985; 28: 412–419. DOI:10.1007/bf00280883.; https://bulletin.tomsk.ru/jour/article/view/1039
-
3Academic Journal
Πηγή: Бюллетень экспериментальной биологии и медицины. 2017. Т. 163, № 2. С. 204-210
Θεματικοί όροι: сперматогониальные стволовые клетки, воспаления, эндотелиальные прекурсоры, эпителиальные прекурсоры, метаболические нарушения
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000587161
-
4Academic Journal
Συγγραφείς: Пахомова, Ангелина Владимировна, Ермолаева, Любовь Александровна, Крупин, Вячеслав Андреевич, Ермакова, Наталия Николаевна, Пан, Эдгар Сергеевич, Кудряшова, А. И., Рыбалкина, Ольга Юрьевна, Павловская, Т. Б., Литвяков, Николай Васильевич, Гольдберг, Виктор Евгеньевич, Дыгай, Александр Михайлович, Першина, Ольга Викторовна, Скурихин, Евгений Германович
Πηγή: Бюллетень экспериментальной биологии и медицины. 2017. Т. 163, № 2. С. 204-210
Θεματικοί όροι: метаболические нарушения, воспаления, сперматогониальные стволовые клетки, эндотелиальные прекурсоры, эпителиальные прекурсоры
Περιγραφή αρχείου: application/pdf
Relation: vtls:000587161; http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000587161